Crohn’s disease is a long-term condition that causes inflammation in the digestive tract, leading to severe pain, diarrhea, weight loss, and fatigue. While scientists have known that factors like genetics, gut bacteria, and the immune system contribute to the disease, new research has now identified a surprising link—Crohn’s disease may also be connected to a virus.
For the first time, researchers have found strong evidence that Epstein-Barr virus (EBV), which is best known for causing mononucleosis (or “mono”), may play a role in the development of Crohn’s disease. Scientists had already noticed that EBV is often present in the intestines of people with Crohn’s.
The virus has also been linked to other autoimmune diseases, such as lupus, multiple sclerosis, and rheumatoid arthritis. However, it was unclear whether EBV triggered Crohn’s disease or if people with Crohn’s were simply more likely to have the virus.
To investigate this, researchers at Boston Children’s Hospital conducted a long-term study that tracked healthy individuals over time to see if EBV exposure could predict the development of Crohn’s disease.
Tracking EBV and Crohn’s Disease
The researchers analyzed data from military recruits who were between 20 and 24 years old. These individuals provided blood samples regularly during their service, allowing scientists to check for antibodies—proteins that the immune system produces when fighting infections.
A special tool called VirScan was used to detect antibodies against a wide range of viruses, providing a detailed history of each person’s past infections.
The results were striking. People who had EBV antibodies in their blood—meaning they had been exposed to the virus—were three times more likely to develop Crohn’s disease compared to those who did not have EBV antibodies. In fact, signs of EBV exposure appeared in their blood five to seven years before they were diagnosed with Crohn’s.
“We weren’t specifically looking for EBV when we started this study,” said Dr. Scott Snapper, the senior investigator. “But when we found it, we did more detailed tests to confirm the results, and they were very clear.”
To further test the connection, the researchers examined a second group of over 5,000 children who had a parent or sibling with Crohn’s disease. In this group, EBV did not significantly predict who would develop Crohn’s.
Scientists believe this may be because these children were already at higher risk due to genetics and shared environmental factors, which could have made it harder to detect the role of EBV.
How EBV Might Trigger Crohn’s Disease
Researchers now want to understand exactly how EBV could make someone more likely to develop Crohn’s. One possibility is that the virus interacts with human genes that are already linked to autoimmune diseases, increasing the risk of immune system problems.
Another theory involves a protein that EBV produces, which is similar to IL-10, a molecule in the human body that reduces inflammation. If a person’s immune system mistakenly attacks this viral protein, it might also interfere with their body’s ability to control inflammation, leading to Crohn’s disease.
The study’s findings could have important implications for treatment. If scientists can understand how EBV affects the immune system, they may be able to develop new therapies to prevent or treat Crohn’s disease.
Review and Analysis
This study is significant because it provides the strongest evidence yet that Epstein-Barr virus may play a role in triggering Crohn’s disease. By analyzing individuals before they were diagnosed, the research suggests that EBV exposure is not just a side effect of Crohn’s but could actually contribute to its development.
However, there are still many unanswered questions. The study found a strong link between EBV and Crohn’s in adults but not in children, suggesting that age or other factors may influence how the virus interacts with the immune system.
Additionally, the study does not prove that EBV directly causes Crohn’s—other factors, such as genetics and environment, likely play a role as well.
Despite these uncertainties, the findings open new doors for research. If EBV is confirmed as a risk factor, it may be possible to develop vaccines, antiviral treatments, or immune therapies to lower the risk of Crohn’s disease. Future studies will focus on understanding the exact biological mechanisms behind this connection and how they can be targeted for treatment.
For now, people with Crohn’s disease or a family history of the condition may want to be aware of their EBV exposure and discuss any concerns with their doctors. Understanding how viruses affect the immune system could be a key step in preventing or managing this challenging disease.
If you care about gut health, please read studies about how probiotics can protect gut health ,and Mycoprotein in diet may reduce risk of bowel cancer and improve gut health.
For more health information, please see recent studies about how food additives could affect gut health, and the best foods for gut health.
The research findings can be found in Gastroenterology.
Copyright © 2025 Knowridge Science Report. All rights reserved.
